The activation of natural killer (NK) cells leads to degranulation and secretion of cytotoxic granula. During this process, the lytic granule membrane protein CD107a becomes detectable at the cell surface. Based on this phenomenon, we have analyzed by a novel flow cytometry-based assay, the number and phenotype of NK cells responding to tumor targets. Using human leukemia and lymphoma cell lines, we observed a close correlation between CD107a surface expression and target cell lysis, indicating that NK cell cytotoxicity can be assessed by this method. The number of degranulating NK cells was closely related to the ratio of effector and target cells and showed a maximum at a ratio of 1:1. Moreover, we were able to show that the population of CD56 dim /CD16 neg NK cells is primarily responsible for the cytotoxic activity against tumor targets whereas neither CD56 dim /CD16 pos nor CD56 bright NK cells degranulated in response to the cell lines. Our results indicate that the CD107a assay represents a promising new method for the quantification and characterization of cells exhibiting natural cytotoxicity.
Introduction
Natural killer (NK) cells are the predominant cytolytic effector cells in innate immunity. They are defined by expression of CD56 and lack of T-cell receptor expression. Different NK cell compartments can be distinguished by the surface density of CD56 and the presence of the Fc gamma receptor III protein CD16. 1, 2 More than 90% of peripheral blood NK cells belong to the CD 56 dim subset, which has been shown to express perforin as well as the killer cell Ig-like receptors (KIRs). A subpopulation of CD56 dim NK cells expresses the Fc receptor CD16 and is involved in antibody-dependent cellular cytotoxicity (ADCC). 3 Perforin and KIRs are not present on CD56 bright NK cells, which are rare in blood but represent the predominant cell type in lymph nodes and tissues. 1 It has been hypothesized that the CD56 bright subset exhibits immunoregulatory functions through the secretion of various cytokines (ie IFN-g, TNF-a, or IL-10), whereas CD56 dim cells are responsible for the cytolytic activity against virally infected cells and autologous tumor cells. 4 Target cell killing by cytotoxic T cells (CTLs) and NK cells mainly relies on degranulation, which leads to the release of lytic granules containing perforin and granzymes. During this process, lysosomal membranes and plasma membranes merge and vesicle membrane proteins become visible on the cell surface. 5 Recently Betts et al 6 reported on the development of a novel multiparameter flow cytometry assay detecting CD8 pos CTL activity by measuring degranulation via expression of the lysosomal-associated membrane protein-1 (CD107a). In a series of experiments, it was shown that CD107a surface mobilization can be used to isolate and analyze cytolytic T cells ex vivo. 7 Wolint et al used CD107a surface expression to study the regulation of cytolytic activity in effector T cells, effector memory T cells and central memory T cells in response to viral targets. They found that degranulation occur with similar kinetics in all T-cell subsets. However, degranulation of central memory T cells was not followed by target cell lysis due to lack of stored cytotoxic effector molecules. 8 Target cell killing via the granule-dependent pathway is a common mechanism of CTLs and NK cells. 9, 10 Recently, a correlation of NK cell cytotoxicity, CD107a surface expression and the level of viral replication was found in HIV-1 infected subjects, suggesting that CD107a expression can serve as a marker for NK cell activity in HIV infection. 11 We examined whether NK cell activation due to tumor targets can be visualized by CD107a surface mobilization and whether degranulation correlates with cytolytic activity. For that purpose we determined the surface expression of CD107a on NK cells of healthy donors after coincubation with different leukemia and lymphoma cell lines. We observed a strong correlation between CD107a surface expression and NK cell cytotoxicity determined in a standard flow cytometry-based cytotoxicity assay. Additionally, we were able to determine NK cell activation in response to tumor targets on a single-cell level which allows to analyze activation of the distinct NK cell subpopulations separately.
Methods

Tumor cell lines
The following human cell lines were obtained from German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany): HEL (ACC11, AML/Erythro-leukemia), 12 HL60 (ACC3, AML), 13 K562 (ACC10, CML in blast crisis), 14 KASU-MI-1 (ACC 220, AML), 15 ML2 (ACC15, AML), 16 EHEB (ACC67, CLL), 17 GRANTA-519 (ACC342, mantle cell lymphoma), 18 JEKO-1 (ACC553, mantle cell lymphoma) and 19 KARPAS-422 (ACC 32, diffuse large cell lymphoma). 20 The EBV-transformed human lymphoblastoid leukemia L721.221 21 cell line was generously provided by Christine S Falk, Institute of Molecular Immunology, GSF National Research Center for the Environment and Health, Munich, Germany.
The cell lines were kept at 371C in incubators and supplied with 5% CO 2 and air in cell suspension cultures consisting of RPMI medium supplemented with 4 mmol/l L-glutamine (Sigma, Munich, Germany), 100 U/ml streptomycin (Sigma), 100 U/ml penicillin (Sigma) and 10% fetal calf serum (FCS; Kraeber, Wedel, Germany). On the day of testing, cell counting was performed with trypan blue to assess cell viability. The target cells were washed once in Roswell Park Memorial Institute 1640 medium (RPMI), resuspended and adjusted to 1 Â 10 6 viable cells/ml in RPMI.
CD107a assay
Peripheral venous blood from healthy individuals was stored in heparinized tubes and peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation on a Ficoll-Paque gradient. The mononuclear cells from the interface were washed twice in phosphate-buffered saline (PBS), resuspended and adjusted to 1 Â 10 6 cells/ml in RPMI, Sigma, Munich, Germany. All experiments were repeated to assess reproducibility. To detect spontaneous degranulation, a control sample without target cells was included in every experiment. An effector/target (E/T) ratio of 1:1 (2 Â 10 5 effector cells: 2 Â 10 5 target cells in a volume of 200 ml) was used in all experiments. In each tube, containing 200 ml E/T cell suspension, 15 ml of PECy5 conjugated anti-CD107a monoclonal antibody (mAb) was added prior to incubation. PBMCs and target cells were coincubated (371C) for 3 h in total, after the first 1 h 5 ml of the secretion inhibitor 2 mM monensin (Sigma, Munich, Germany) in 100% ethanol was added. Degranulating effector cells express CD107a on the cell surface as early as 30 min to 1 h following stimulation. As optimal expression of CD107a occurs between 3 and 6 h poststimulation, we chose the 3 h coincubation period. 6, 7, 11 At the end of coincubation, cells were washed in PBS and stained with mAbs (CD56, CD16) for flow cytometric analysis. CD56 pos cells, which accounted for 10-30% of the gated lymphocytes, were divided into three compartments: CD56 Cytotoxicity assay NK-cell-mediated cytotoxicity was analyzed as described previously. 22 Briefly, target cells were stained with 3,3 0 -dioctadecyloxacarbocyanine (DiO; Sigma, Munich, Germany) solution for 20 min at 371C. After washing the target cells with PBS, NK cells and target cells (E:T ratios: 100:1, 50:1, 20:1 and 10:1) were coincubated for 4 h in RPMI medium. Dead cells were counterstained using propidium iodide (Sigma) solution and analyzed by flow cytometry. DiO-labeled target cells emit a green fluorescence and propidium iodide-stained target cells emit a red fluorescence, which where detected by flow cytometry. To determine the specific lysis of target cells, the degree of spontaneous cell death was assessed by examining a sample containing target cells only.
Cytotoxicity assay after CD107a positive selection
To investigate if CD107a pos NK cells rather than CD107a neg NK cells mediate cytotoxicity, we isolated CD56 pos cells from healthy donors PBMC by positive selection with anti-CD56 magnetic beads (Miltenyi Biotec, Bergish Gladbach, Germany). Subsequently we performed the CD107a assay as described above (CD56 pos PBMC: K562 ratio ¼ 1:1). After the 180-min incubation period we positively selected CD107a pos cells by using anti-CD107a PE conjugated mABs followed by anti-PE magnetic beads (Miltenyi Biotec). Cytotoxicity was assessed separately in the two cell fractions (CD56 pos / CD107a pos and CD56 pos / CD107a neg ).
Antibodies and flow cytometry
Analysis of cell surface markers was performed using the following anti-human fluorescent conjugated mAbs (BD Pharmingen, Hamburg, Germany) in direct immunofluorescence assays: Anti-CD16 FITC (fluorescein isothiocyanate), anti-CD56 PE (phycoerythrin), anti-CD107a PE and anti-CD107a PE-Cy5 (phycoerythrin-Cy5). Antibody concentrations were adjusted according to the protocol of the manufacturer. Flow cytometric analysis was performed by a FACScalibur cytometer (BD Pharmingen). In all experiments at least 30 000 events were counted and the results were expressed as the percentage of cells in a gated lymphocyte region.
Results
Activated NK cells express CD107a
To assess the degranulation of NK cells in response to tumor targets, we examined the surface expression of CD107a after coincubation of PBMC with the NK-sensitive cell line K562 and the NK-resistant cell line ML2. No CD107a expression was detected on resting NK cells (Figure 1c ). After coincubation with K562 cells up to 6% of CD56 pos cells expressed CD107a, indicating that a subpopulation of NK cells releases cytotoxic granules after contact with these target cells (Figure 1a) . In contrast, coincubation with NK-resistant ML2 leukemia cells was not followed by an increased surface expression of CD107a (Figure 1b) .
Induction of CD107a expression depends on E/T ratios
To determine the influence of different E/T ratios on NK cell activation, as indicated by CD107a expression, we performed the assay after immunomagnetic selection of CD56 pos PBMCs from healthy donors. The NK-sensitive cell lines HL60 and K562 were added in E/T ratios ranging from 1:50 to 50:1. As shown in Figure 2 for one example, the highest CD107a surface expression was detected in the 1:1 E/T ratio. Figure 3a ). As demonstrated in Figure 3b, (Figures 3c and d) . Similar results were obtained in experiments with NK cells from six healthy donors and other target cell lines (Figure 4) , suggesting that the CD56 dim CD16
neg subset contains the majority of cytotoxic NK cells.
CD107a expression predicts NK cell activity as determined by tumor cell lysis
To investigate whether CD107a surface expression is predictive for cytolytic activity, we performed a flow cytometric cytotoxicity assay with the myeloid cell lines used for the CD107a assay. As shown in Figure 5 , CD107a surface expression and specific lysis demonstrated a strong positive correlation (r 2 ¼ 0.99 for E/T ratios of 1:1 and 10:1, respectively). pos / CD107a pos cell fraction exhibited significant cytotoxic activity against leukemia targets, whereas CD56 pos /CD107a neg NK cells were not able to lyse K562 cells ( Figure 6 ).
Discussion
Since NK cell-mediated cytotoxicity is a major defense mechanism against tumor cells, methods evaluating NKmediated target cell killing and NK cell activity are of great interest. Although the chromium (51 Cr ) release assay has several inherent problems, including hazards associated with radioactivity, cell labeling and high spontaneous release, it has become the standard method for assessing lymphoid, including NK cell, cytotoxicity. 23 In recent years flow-cytometric assays, based on the release of fluorescent dyes from target cells or propidium iodide uptake, have been introduced as alternatives for the chromium release assay. They provide several advantages such as avoidance of radioactive reagents and detection of cytotoxicity at the single-cell level. 24 However, neither the chromium release nor cytometric assays measure NK cell activation directly but rather examine the death of target cells. 25 Thus far, methods directly assessing NK cell activation were based on the detection of cytokine production or secretion. Among these methods, ELISpot analysis and ICS (intracellular cytokine staining) are most commonly used. 26 They do not allow conclusions regarding the cytotoxic potential of NK cells.
Based on the recently described phenomenon that the degranulation of CTLs is followed by expression of the lysosomal-associated membrane protein-1 (CD107a), 6 we assessed NK cell activity in response to different tumor targets by flow cytometric detection of CD107a. This new technique has numerous advantages over the existing standard methods. The main advantage of this simple assay is the opportunity to easily identify cytotoxic NK cells on a single-cell level by flow cytometry. The finding that degranulation of CD8 pos memory T cells leads only to low level immediate cytotoxicity due to small amounts of stored cytotoxic effector molecules suggest that CD107a surface mobilization does not necessarily correlate with the cytolytic ability in CTLs. 8 We found that degranulation of NK cells in response to tumor targets lead to tumor cell lysis. In this report, we have demonstrated that the CD107a assay reliably predicts NK cell cytotoxicity against different target cells. We showed that CD56 pos /CD107 pos cells that have been immunomagnetically selected after stimulation with K562 are highly cytotoxic whereas CD56 pos /CD107a neg cells are not cytotoxic. The positive correlation between CD107a surface mobilization and the results of a standard flow cytometric cytotoxicity assay suggests that the CD107a assay can be used to assess the individual amount of cytotoxic NK cells at a given time point against a standardized tumor target. Moreover, it allows comparing the capability of different tumor cells to activate cytotoxic NK cells. Its performance is relatively easy and the time required is considerably shorter compared to other assays.
Another striking advantage of the novel method is the flow cytometric acquisition, which not only allows gating out disturbing T cells and monocytes but also permits additional staining of other cell surface molecules, as for example Fc receptors, homing receptors or KIRs. Separate examination of different NK subpopulations will provide new insights into the mechanisms of NK cell activation and cytotoxicity.
As a first example for such an application, we have investigated the level of CD107a surface mobilization in three 'classical' NK cell subsets in response to myeloid leukemia cells. It is well known that CD56-positive NK cells can be divided into a CD56 dim and CD56 bright population. While the CD56 dim population dominates in the peripheral blood and contains mature NK cells with cytotoxic function, the CD56 bright population is primarily located in the lymph nodes and exhibits Percentage of CD107a pos cells in peripheral blood NK cell subsets after coincubation with myeloid cell lines. The NK cell subsets were defined and gated as shown in Figure 3 neg , during NK cell differentiation CD16 expression increases with impact on NK cell functionality. [29] [30] [31] [32] [33] [34] In all tests, no considerable expression of CD107a was detected on CD56 dim /CD16 pos cells, indicating that these cells do not degranulate in response to NK-sensitive leukemia targets and do not exhibit direct cytotoxicity. Since CD16 surface expression is crucial for antibody-dependent cellular cytotoxicity, it is reasonable that the CD56 dim /CD16 pos cells are the major effector cells mediating this type of cytotoxic response. 3 We are currently investigating whether CD107a expression is induced in the CD56 dim /CD16 pos cell fraction when the target cell is coated with a relevant antibody, which would extend the application of this assay to antibody-dependent cellular cytotoxicity.
In summary, we have presented a novel flow cytometric assay, which detects NK cell degranulation as a reliable indicator of NK cell activation. Using this method we showed that NK-cell-mediated cytotoxicity against tumor targets is restricted to the CD56 dim /CD16 neg subpopulation. The assay is highly sensitive and its results are strictly correlated with NK cell cytotoxicity. The simple and rapid performance makes it a suitable method not only for the scientific analysis of factors influencing NK cell activation on a single cell level but also for broad clinical use to assess NK cell activity in immunocompromised patients.
Figure 5
Correlation of CD107a surface expression and cytotoxicity. CD107a surface expression (%) in CD56 pos PBMC of six normal donors after coincubation with myeloid leukemia cell lines (a) in relation to specific lysis (%) determined by flow cytometric measurement of NK cytotoxicity using propidium iodide uptake to detect cell death (b). The correlation of CD107a surface mobilization (E/T ratio of 1:1) and specific lysis (E/T ratio of 10:1) demonstrates a close relationship (c).
Figure 6
Specific lysis against K562 target cells in CD56 pos / CD107a pos and CD56 pos /CD107a neg PBMC. NK cell populations were selected by microbeads after coincubation with K562 cells. NK-cellmediated cytotoxicity is restricted to the CD107a pos cell fraction, as indicated by a high percentage of specific lysis in contrast to the CD107a neg cell fraction. 
